CHLAMYDIA TRACHOMATIS AND HUMANPAPILLOMA VIRUS 16 AND 18 IN ADOLESCENTS
Abstract
Background. Adolescents represent a risk group for sexually transmitted infections. The aim of this study was to find the incidence of Chlamydia trachomatis (CT) and human papillomavirus (HPV) in adolescents. Additionally, we wanted to know, whether the prevalence of CT was so high that antibiotic prophylaxis would be appropriate before termination of pregnancy.
Patients and methods. In the study 200 adolescents aged 15 to 19 years were enrolled: 100 came for termination of pregnancy and 100 for a contraceptive method. In all cases the cervical smears were taken for culture and direct immunofluorescence (DIF) for CT. The cervical smear was used also for hybridization test for the detection of HPV 16 and HPV 18. Serologic analysis for hepatitis B, HIV and syphilis were done in all cases.
Results. CT was isolated in 6% in the first and in 4% in the second group Using DIF method CT was confirmed in 7% in the first and in 4% in the second group. HPV 16 or 18 was positive in 26% in the first and in 13% in the second group. We did not find any case of syphilis, HIV and hepatitis.
Conclusions. A 6% prevalence of CT justifies the use of antibiotic prophylaxis before termination of pregnancy.
Downloads
References
Henry Suchet J, Sluzhinska A, Serfaty D. Chlamydia trachomatis screening in family planning centers: a review of cost / benefit evaluations in different countries. Eur J Contracept Reprod Health Care 1996; 1: 301–9.
Mangione-Smith R, O’Leary J, McGlynn EA. Health and cost-benefits of chlamydia screening in young women. Sex Transm Dis 1999; 26: 309–16.
Kim JJ, Wright TC, Goldie SJ. Cost-effectivness of alternative triage strategies for atypical squamous cells of undetermined significance.JAMA 2002; 287: 2382–90.
Manos MM. Utility of HPV DNA testing and liquid-based cytology in the triage of women with mild Pap abnormalities. JAMA 1999; 281: 1605–10.
Ho GY, Bierman R, Beardsley L et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423– 8.
Bosch FX, Manos MM, Muńoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796–802.
Stoler MH. Human papillomaviruses and cervical neoplasia: A model for carcinogenesis. Int J Gynecol Pathol 2000; 19: 16–28.
Whiteside JL, Katz T, Anthes T et al. Risks and adverse outcomes of sexually transmitted diseases. Patients’ attitudes and beliefs. J Reprod Med 2001; 46: 34–8.
CDC 1998 Guidelines for treatment of sexually transmitted diseases. MMWR 1998; 47 (No. RR-1).
Plummer FA, Simonsen JN, Cameron DW et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163: 233–9.
Qvigstad E, Skaug K, Jerve F et al. Pelvic inflammatory disease associated with Chlamydia trachomatis infection after therapeutic abortion. A prospective study. Br J Vener Dis 1983; 59: 189-92.
Chernesky MA, Lee H, Schachter J et al. Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing firstvoid urine in a ligase chain reaction assay. J Infect Dis 1994; 170: 1308–11.
Lee HH, Chernesky MA, Schachter J et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995; 345: 213–6.
Vogels WH, van Voorst Vader PC, Schroder FP. Chlamydia trachomatis infection in a high-risk population: comparison of polymerase chain reaction and cell culture for diagnosis and follow-up. J Clin Microbiol 1993; 31: 1103–7.
Bauwens JE, Clark AM, Stamm WE. Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol 1993; 31: 3023–7.
Dallabetta GA, Gerbase AC, Holmes KK. Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Infect 1998; 74 Suppl 1: S1–11.
Nobbenhuis MAE, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 1999; 354: 20–5.
Ho GY, Burk RD, Klein S, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365–71.
Cuzick J, Beverley E, Ho L, et al. HPV testing in primary screening of older women. Br J Cancer 1999; 8 1: 554–8.
Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvares FB, Chiacchierini LM, Jansen KU. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 21: 177–05.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
